Jpmorgan Chase & CO Iradimed Corp Transaction History

Jpmorgan Chase & CO

$1.23 Trillion
Q4 2024

A detailed history of Jpmorgan Chase & CO transactions in Iradimed Corp stock. As of the latest transaction made, Jpmorgan Chase & CO holds 46,483 shares of IRMD stock, worth $2.57 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

46,483

Previous 29,226 59.05%

Holding current value

$2.57 Million

Previous $1.47 Million 74.0%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	BUY	$48.3 - $57.35 $833,513 - $989,688	17,257 Added 59.05%	46,483 $2.56 Million
Q3 2024 Dec 26, 2024	BUY	$43.23 - $50.29 $520,964 - $606,044	12,051 Added 70.17%	29,226 $1.47 Million
Q3 2024 Nov 08, 2024	BUY	$43.23 - $50.29 $520,964 - $606,044	12,051 Added 70.17%	29,226 $1.47 Million
Q2 2024 Dec 26, 2024	SELL	$40.36 - $44.7 $486,378 - $538,679	-12,051 Reduced 41.23%	17,175 $754,000
Q2 2024 Aug 12, 2024	SELL	$40.36 - $44.7 $567,542 - $628,571	-14,062 Reduced 45.02%	17,175 $754,000
Q1 2024 Dec 26, 2024	BUY	$41.17 - $47.29 $82,792 - $95,100	2,011 Added 6.88%	31,237 $1.37 Million
Q1 2024 May 10, 2024	BUY	$41.17 - $47.29 $515,613 - $592,259	12,524 Added 66.93%	31,237 $1.37 Million
Q4 2023 Dec 26, 2024	SELL	$37.31 - $47.47 $392,240 - $499,052	-10,513 Reduced 35.97%	18,713 $888,000
Q4 2023 Feb 12, 2024	SELL	$37.31 - $47.47 $41,078 - $52,264	-1,101 Reduced 5.56%	18,713 $888,000
Q3 2023 Nov 14, 2023	BUY	$43.28 - $50.3 $227,955 - $264,930	5,267 Added 36.21%	19,814 $879,000
Q2 2023 Aug 11, 2023	BUY	$38.88 - $50.61 $221,071 - $287,768	5,686 Added 64.17%	14,547 $694,000
Q1 2023 May 18, 2023	BUY	$28.48 - $42.14 $155,472 - $230,042	5,459 Added 160.46%	8,861 $348,000
Q1 2023 May 11, 2023	SELL	$28.48 - $42.14 $19,252 - $28,486	-676 Reduced 16.58%	3,402 $133,000
Q4 2022 Feb 13, 2023	BUY	$26.9 - $30.58 $4,223 - $4,801	157 Added 4.0%	4,078 $115,000
Q3 2022 Nov 14, 2022	BUY	$29.42 - $42.25 $2,324 - $3,337	79 Added 2.06%	3,921 $118,000
Q2 2022 Aug 11, 2022	SELL	$30.15 - $45.79 $202,185 - $307,067	-6,706 Reduced 63.58%	3,842 $130,000
Q1 2022 May 11, 2022	SELL	$36.01 - $53.14 $224,270 - $330,955	-6,228 Reduced 37.12%	10,548 $472,000
Q4 2021 Feb 10, 2022	BUY	$32.35 - $48.27 $239,939 - $358,018	7,417 Added 79.25%	16,776 $774,000
Q3 2021 Nov 12, 2021	BUY	$29.5 - $37.21 $276,090 - $348,248	9,359 New	9,359 $315,000

Others Institutions Holding IRMD

# of Institutions

164

Shares Held

6.78M

Call Options Held

600

Put Options Held

900

View Full List

About IRADIMED CORP

Ticker IRMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 12,565,100
Market Cap $694M
Description
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible pati...

More about IRMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Iradimed Corp Transaction History